Pfizer says drug shows promise vs pancretic cancer

Reuters: "NEW YORK, June 4 (Reuters) - Pfizer Inc. (PFE.N: Quote, Profile, Research) on Monday said its experimental drug axitinib showed promise in a mid-stage trial as a treatment for patients with advanced pancreatic cancer. The company said the oral drug, when combined with the standard treatment Gemzar, 'showed a trend towards prolonged overall survival,' compared with treatment with Gemzar alone. "